UK markets closed

GenSight Biologics S.A. (SIGHTP.XC)

Cboe UK - Cboe UK Real-time price. Currency in EUR
Add to watchlist
0.5400-0.0130 (-2.35%)
At close: 04:29PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
1,267
1,267
2,582
5,276
4,394
-
Operating expenses
Research development
19,360
19,360
19,343
22,554
21,989
-
Selling general and administrative
7,267
7,267
8,237
5,894
3,484
-
Total operating expenses
30,963
30,963
30,417
33,401
29,329
-
Operating income or loss
-29,696
-29,696
-27,835
-28,125
-24,935
-
Interest expense
3,152
3,152
2,650
2,166
1,717
-
Income before tax
-26,221
-26,221
-27,619
-28,615
-34,015
-
Income tax expense
0
0
5
2
2
-
Income from continuing operations
-26,221
-26,221
-27,624
-28,617
-34,017
-
Net income
-26,220
-26,220
-27,625
-28,617
-34,015
-
Net income available to common shareholders
-26,220
-26,220
-27,625
-28,617
-34,015
-
Basic EPS
-0.63
-
-0.60
-0.63
-0.97
-1.09
Diluted EPS
-0.63
-
-0.60
-0.63
-0.97
-1.09
Basic average shares
46,205
-
46,330
45,151
35,127
28,382
Diluted average shares
46,205
-
46,330
45,151
35,127
28,382